Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Maria, Dumitrascuta"'
Publikováno v:
Molecules, Vol 27, Iss 24, p 8785 (2022)
There is still an unmet clinical need to develop new pharmaceuticals for effective and safe pain management. Current pharmacotherapy offers unsatisfactory solutions due to serious side effects related to the chronic use of opioid drugs. Prescription
Externí odkaz:
https://doaj.org/article/9931d7c9ca14407e88471dc1a03c3718
Autor:
Maria Dumitrascuta, Marcel Bermudez, Olga Trovato, Jolien De Neve, Steven Ballet, Gerhard Wolber, Mariana Spetea
Publikováno v:
Molecules, Vol 26, Iss 11, p 3267 (2021)
Opioids are the most effective analgesics, with most clinically available opioids being agonists to the µ-opioid receptor (MOR). The MOR is also responsible for their unwanted effects, including reward and opioid misuse leading to the current public
Externí odkaz:
https://doaj.org/article/cf0ea917f0194797b4d8986faa2d4631
Publikováno v:
Molecules, Vol 25, Iss 9, p 2087 (2020)
The mu opioid receptor (MOR) is the primary target for analgesia of endogenous opioid peptides, alkaloids, synthetic small molecules with diverse scaffolds, and peptidomimetics. Peptide-based opioids are viewed as potential analgesics with reduced si
Externí odkaz:
https://doaj.org/article/85cd8759a62b46fa8adb6ffb1d6cb1a5
Autor:
Simon Gonzalez, Dirk Tourwé, Philippe Sarret, Mariana Spetea, Florine Cavelier, Santo Previti, Charlotte Martin, Linda Kunze, Mélanie Vivancos, Stevany Louis, Louis Gendron, Elke Dewolf, Maria Dumitrascuta, Steven Ballet, Emilie Eiselt, Annalisa Blasiol
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, American Chemical Society, 2020, 63 (21), pp.12929-12941. ⟨10.1021/acs.jmedchem.0c01376⟩
Journal of Medicinal Chemistry, American Chemical Society, 2020, 63 (21), pp.12929-12941. ⟨10.1021/acs.jmedchem.0c01376⟩
International audience; Fusion of nonopioid pharmacophores, such as neurotensin, with opioid ligands represents an attractive approach for pain treatment. Herein, the μ-/δ-opioid agonist tetrapeptide H-Dmt-D-Arg-Aba-β-Ala-NH 2 (KGOP01) was fused t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d847dbf764c975a594956d0282309fc
https://biblio.vub.ac.be/vubir/optimized-opioidneurotensin-multitarget-peptides-from-design-to-structureactivity-relationship-studies(b5565787-3be0-4e48-8dac-9092ed30584e).html
https://biblio.vub.ac.be/vubir/optimized-opioidneurotensin-multitarget-peptides-from-design-to-structureactivity-relationship-studies(b5565787-3be0-4e48-8dac-9092ed30584e).html
Autor:
Marieta Georgieva, Wenlong Huang, Alasdair Leeson-Payne, Maria Dumitrascuta, Marzia Malcangio, Ann M. Rajnicek
Publikováno v:
Georgieva, M, Leeson-Payne, A, Dumitrascuta, M, Rajnicek, A, Malcangio, M & Huang, W 2018, ' A refined rat primary neonatal microglial culture method that reduces time, cost and animal use ', Journal of Neuroscience Methods . https://doi.org/10.1016/j.jneumeth.2018.04.017
Background Primary microglial cultures have been used extensively to facilitate the development of therapeutic strategies for a variety of CNS disorders including neurodegeneration and neuropathic pain. However, existing techniques for culturing thes
Autor:
Nanna B. Finnerup, Wenlong Huang, Roger G. Pertwee, Yuting Wei, Marieta Georgieva, Maria Dumitrascuta
Publikováno v:
Georgieva, M, Wei, Y, Dumitrascuta, M, Pertwee, R, Finnerup, N B & Huang, W 2019, ' Fatty acid suppression of glial activation prevents central neuropathic pain after spinal cord injury ', Pain, vol. 160, no. 12, pp. 2724-2742 . https://doi.org/10.1097/j.pain.0000000000001670
About half of patients with spinal cord injury (SCI) develop debilitating central neuropathic pain (CNP), with no effective treatments. Thus, effective, safe, and novel therapies are needed urgently. Previously, docosahexaenoic acid (DHA) was reporte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2475aa083325561f5c6e7c5dfb72a48
https://pure.au.dk/portal/da/publications/fatty-acid-suppression-of-glial-activation-prevents-central-neuropathic-pain-after-spinal-cord-injury(5b964788-e355-4dc7-9e18-4086aa383427).html
https://pure.au.dk/portal/da/publications/fatty-acid-suppression-of-glial-activation-prevents-central-neuropathic-pain-after-spinal-cord-injury(5b964788-e355-4dc7-9e18-4086aa383427).html
Autor:
Maria Dumitrascuta, Dominik Bucher, Katja Walker, Mariana Spetea, Ann Van Eeckhaut, Morgane Mannes, Sophie Hernot, Yannick Van Wanseele, Richard Hoogenboom, Aquilino Lantero, Edith Oyen, Annemieke Madder, Charlotte Martin, Steven Ballet
Publikováno v:
JOURNAL OF MEDICINAL CHEMISTRY
Chronic pain is currently treated with opioids that offer unsatisfactory long-term analgesia and produce serious side effects. There is a clear need for alternative therapies. Herein, peptide-based hydrogels are used as extended-release drug delivery
Autor:
Armand Drieu la Rochelle, Karel Guillemyn, Maria Dumitrascuta, Simon Gonzalez, Charlotte Martin, Valérie Utard, Raphaëlle Quillet, Séverine Schneider, François Daubeuf, Tom Willemse, Pieter Mampuys, Bert Maes, Nelly Frossard, Frédéric Bihel, Mariana Spetea, Frédéric Simonin, Steven Ballet
Publikováno v:
Proceedings of the 35th European Peptide Symposium.
Autor:
Steven Ballet, Armand Drieu la Rochelle, Pieter Mampuys, Valérie Utard, Frédéric Bihel, Séverine Schneider, Mariana Spetea, François Daubeuf, Karel Guillemyn, Tom Willemse, Maria Dumitrascuta, Nelly Frossard, Bert U. W. Maes, Raphaëlle Quillet, Charlotte Martin, Frédéric Simonin
Publikováno v:
Pain
PAIN
PAIN, Elsevier, 2018, 159 (9), pp.1705-1718. ⟨10.1097/j.pain.0000000000001262⟩
PAIN
PAIN, Elsevier, 2018, 159 (9), pp.1705-1718. ⟨10.1097/j.pain.0000000000001262⟩
Opioid analgesics, such as morphine, oxycodone and fentanyl, are the cornerstones for treating moderate to severe pain. However, upon chronic administration, their efficiency is limited by prominent side effects such as analgesic tolerance and depend
Autor:
Maria, Dumitrascuta, Tanila, Ben Haddou, Elena, Guerrieri, Stefan M, Noha, Lea, Schläfer, Helmut, Schmidhammer, Mariana, Spetea
Publikováno v:
Journal of Medicinal Chemistry
Position 6 of the morphinan skeleton plays a key role in the μ-opioid receptor (MOR) activity in vitro and in vivo. We describe the consequence of the 6-carbonyl group deletion in N-methylmorphinan-6-ones 1–4 on ligand–MOR interaction, signaling